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Abstract
Background
This study analyzes the trajectories of antibiotic consumption using different indicators of
patients’ socioeconomic status, category and age-group of physicians.
Methods
This study uses a pooled, cross-sectional, time series analysis. The data focus on 22 Euro-
pean countries from 2000 to 2014 and were obtained from the European Center for Disease
and Control, Organization for Economic Co-operation and Development, Eurostat and
Global Economic Monitor.
Results
There are large variations in community and hospital use of antibiotics in European coun-
tries, and the consumption of antibiotics has remained stable over the years. This applies to
the community (b = 0.07, p = 0.267, 95% -0.06, 0.19, b-squared <0.01, p = 0.813, 95% =
-0.01, 0.02) as well as the hospital sector (b = -0.02; p = 0.450; CI 95% = -0.06, 0.03; b-
squared <0.01; p = 0.396; CI95% = > -0.01, <0.01). Some socioeconomic variables, such
as level of education, income, Gini index and unemployment, are not related to the rate of
antibiotic use. The age-group of physicians and general practitioners is associated with the
use of antibiotics in the hospital. An increase in the proportion of young doctors (<45 years
old) leads to a significant increase in antibiotics consumption, and as the percentage of gen-
eralist practitioners increases, there use of antibiotics in hospitals decreases by 0.04 DDD/
1000 inhabitants.
Conclusions
Understanding that age-groups and categories (general/specialist practitioners) of physi-
cians may predict antibiotic consumption is potentially useful in defining more effective
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health care policies to reduce the inappropriate antibiotic use while promoting rational
use.
Introduction
Antibiotic resistance is a major public-health problem of global importance because it is
related to treatment failure, increased use of health care services and increased mortality [1,2].
Consumption and over-consumption of antibiotics are recognized as the main cause of antibi-
otic resistance.
In response to this problem, the European Union put in place over time community strate-
gies and action plans supporting, as pillar, antimicrobial stewardship, defined as a coherent set
of actions which promote using antimicrobials responsibly. Antimicrobial stewardship aimed
to provide evidence-based data on possible links between consumption of antimicrobial agents
and the occurrence of antimicrobial resistance in humans and food-producing animals and,
then, to develop EU guidelines for the prudent use of antimicrobials in human medicine and
to assist Member States implement EU guidelines for the prudent use of antimicrobials in vet-
erinary medicine [3]. At national level in Europe, many countries have implemented antibiotic
stewardship programmes, at national or regional level. These initiatives provide for local sur-
veillance of antibiotic consumption, systematic measuring, evaluating & improving quality of
antibiotic usage, regular training of prescribing physicians and other relevant healthcare work-
ers in diagnostics, treatment and prophylaxis of infections, focusing on appropriate use of anti-
microbial agents as well as prevention and control of antimicrobial resistance. For example
some antibiotic stewardship strategies in European countries are based on educational
resources (UK and Germany), on public reporting with the data on antibiotic consumption
and resistance for hospital and primary care publicly available on a website (UK) or on cross-
sectoral antibiotic stewardship networks implemented in different settings (hospital, primary
care, long-term care facilities) and at local, regional and national levels (Sweden France, Spain)
[4,5]. Reliable and comparable data on the patterns of national antibiotic drug use and distri-
bution are the starting point for analyzing the antibiotic resistance problem.
Since late 2005, the understanding and the measurement of inequalities in health and
health-care use has been identified as a priority by the WHO Commission on Social Determi-
nants of Health[6]. Several studies have investigated the role of socioeconomic determinants
in facilitating inequalities in health and health-care use. Most of the previous studies that
assessed the impact of socioeconomic determinants on antibiotic consumption have focused
on different countries and time-points[7,8]. The few ones analyzing the role of socioeconomic
determinants on antibiotic consumption at the European level have focused on different set-
tings, such as the hospital or outside the hospital [9,10].
Several studies measure particular aspects of socioeconomic parameters, such as educa-
tional level, rather than investigate a set of two or more determinants.
This study analyzes the trajectories of antibiotic use across 22 EU countries and it assesses: (i)
how the antibiotic consumption has changed in the community and hospital sectors over a 15-year
period; (ii) the correlations between antibiotic use and a variety of socioeconomic determinants;
(iii) the correlations between antibiotic use and categories of prescribing physicians or age of physi-
cian, which is used as a proxy for experience, and the background of the prescribing physician.
Methods
This study used a pooled cross-sectional time series analysis of secondary data for 22 European
countries between 2000 to 2014. These countries and years were chosen based on the availability
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of data. The unit of analysis was each country in each year (country-year). The countries
included in the study were the following: Austria, Belgium, Czech Republic, Denmark, Estonia,
Finland, France, Germany, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg,
Netherlands, Norway, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
Official data were obtained from the European Center for Disease and Control (ECDC),
Organization for Economic Co-operation and Development (OECD), Eurostat and Global
Economic Monitor (GEM). The indicators considered are related to: the consumption of anti-
biotics in two different sectors, that are primary care and hospital; the prescribing physicians
stratified in five age groups, which are 35–44, 45–54, 55–64, 65–74; the physician categories,
that are generalist, specialist and not further defined medical doctors; and related to socio-eco-
nomic determinants such as the GINI coefficient, household income and education level of
the population aged 25–64, stratified into three classes.
These indicators are shown in Table 1, which illustrates the definition and source for each
of them.
Table 1. Variables, indicators, definitions and data sources.
Indicators Definition Source
1 Consumption of Antibacterials for Systemic Use (ACT group J01) in
primary care sector
DDD per 1000 inhabitants and per day ECDC 2017
2 Consumption of Antibacterials for Systemic Use (ACT group J01)
hospital sector
DDDα per 1000 inhabitants and per day in ECDC 2017
3 Gini Coefficient of equivalised disposable income Gini coefficientβ (scale 0 to 100) EUROSTAT 2017
4 Income of householdsγ –Disposable income Euro per inhabitant EUROSTAT 2017
5 Educational attainment levelδ (0–2)—population 25–64 years Less than primary, primary and lower secondary
education (%)
EUROSTAT 2017
6 Educational attainment levelδ (3 and 4)—population 25–64 years Upper secondary and post-secondary non-tertiary
education (%)
EUROSTAT 2017
7 Educational attainment levelδ (5–8)—population 25–64 years Tertiary education (%) EUROSTAT 2017
8 Unemployment Total (% of total labor force) (modeled ILO
estimate)
GLOBAL ECONOMIC
MONITOR 2017
9 Physicians—under 35 years old % of total physicians (head counts) OECD 2017
10 Physicians—35–44 years old % of total physicians (head counts) OECD 2017
11 Physicians—45–54 years old % of total physicians (head counts) OECD 2017
12 Physicians—55–64 years old % of total physicians (head counts) OECD 2017
13 Physicians—65–74 years old % of total physicians (head counts) OECD 2017
14 Physicians—Generalist medical practitioners % of total physicians (head counts) OECD 2017
15 Physicians—Specialist medical practitioners % of total physicians (head counts) OECD 2017
16 Physicians—Medical doctors not further defined % of total physicians (head counts) OECD 2017
Abbreviations: OECD, Organization for Economic Co-operation and Development; ECDC, European Center of Disease and Control; DDD, Defined Daily Dose.
α: The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. This indicator is used to assess antibiotic use in the
hospital sector and the community and it is an internationally accepted parameter for making comparisons between countries
β: Gini Coefficient: the Gini coefficient measures the extent to which the distribution of income within a country deviates from a perfectly equal distribution. The
perfect equality is expressed with 0 and full inequality is expressed with 100.
γ: total disposable income of a household is calculated by adding together the personal income received by all of household members plus income received at household
level; that includes: all income from work (employee wages and self-employment earnings); private income from investment and property; transfers between
households; all social transfers received in cash including old-age pensions.
δ: the level of educational attainment is defined according to the International standard classification of education (ISCED). The educational attainment level of an
individual is the highest ISCED level successfully completed. Educational attainment levels are usually presented for three main categories: i) less than primary, primary
and lower secondary education (ISCED 2011 levels 0–2); ii) upper secondary and post-secondary non-tertiary education (ISCED 2011 levels 3 and 4); iii) tertiary
education (ISCED 2011 levels 5–8).
https://doi.org/10.1371/journal.pone.0199436.t001
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Statistical analyses
To assess the relationship between dependent and independent variables over the 15-year
study period, the study adopted a pooled, cross-sectional, time series design. Specifically, this
design involved observing the variables for different cross-sections over a given timespan [11].
The dependent variables were indicators 1 and 2, while the independent variables were indica-
tors 3 to 16.
A fixed-effects linear regression was done by performing a Hausman test with Sigmamore
option [12] because the random-effects specification was found to be inappropriate for coun-
try-level effects in the adopted model. One advantage of fixed-effects models is that they con-
trol for time-invariant heterogeneity among countries [13]. The presence of exogenous time
trends in both the dependent and independent variables (i.e., time-fixed effects) was controlled
by adding dummy variables to the model for each of the study years except the first.
To avoid model overfitting, indicators 3 to 16 were halved by collapsing age groups, while
secondary and tertiary education levels (6 and 7) were merged because they gave similar
results. Additionally, no results were reported for indicators 9 and 16 because they comple-
ment the 100 indicators shown in the Results section. The relationship between all the remain-
ing dependent and independent variables were separately examined, resulting in 12 distinct
fixed-effects models. This choice was driven primarily by concerns about model over-fitting
and multicollinearity.
For all the analyses, the significance level was set at p< 0.05, and listwise deletion was used.
The significance of each independent variable was assessed using robust standard errors due
to results obtained from performing a modified Wald test for group-wise heteroskedasticity in
the regression residuals [14]. All data sets were analyzed using the Stata software package, ver-
sion 13 (StataCorp. 2013, Stata Statistical Software: Release 13; StataCorp LP, College Station,
TX, USA).
Results
The antibiotic use patterns in hospital and community settings is shown in Fig 1.
The figure reveals considerable variability among the countries regarding the consumption
in primary care sector in 2014. The consumption pattern in the Netherlands was approxi-
mately 10 DDD, while in Belgium, France, Italy and Luxembourg, the pattern was approxi-
mately 30 DDD at the end of the observation period. Five countries (Belgium, France, Italy,
Luxembourg, and Slovakia) had DDD values above 24 in 2014. However, the DDD values
were already high for these countries in 2000.
The results show that hospital use of antibiotics, which is poorly reported in the ECDC
database, is very low. Eight countries (Latvia, Finland, France, Lithuania, Denmark, Italy, Slo-
vakia, and the UK) had DDD values above 2 in 2014. In the hospital sector, the variability was
very high, indeed 3 of the countries (Latvia, Finland, France) started with a higher value, 2 of
the countries (Lithuania, UK) had a constant DDD and 3 of the countries (Italy, Slovakia, Den-
mark) started with a lower value.
The fixed effects regression model confirmed the evidence of this first graphic analysis. Lin-
ear and quadratic terms were not significant and these apply to the community (b = 0.07,
p = 0.267, 95% -0.06, 0.19, b-squared <0.01, p = 0.813, 95% = -0.01, 0.02) as well as the hospital
sector (b = -0.02; p = 0.450; CI 95% = -0.06, 0.03; b-squared <0.01; p = 0.396; CI95% =>
-0.01, <0.01).
According to the results, some socioeconomic variables, such as level of education, income,
Gini index and unemployment, were not related to the rate of antibiotic consumption both in
hospital and in the community (Table 2). Similarly, the variables related to the age and
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category of prescribing physicians were not related to the rate of antibiotic consumption in the
community.
The only significant findings relate to the association between the consumption of antibiot-
ics in the hospital and some prescribing physicians’ characteristics, age and category. Our
results highlight that an increase of a percentage-point of doctors between 35 and 44 years of
age led to an average increase of 0.08 in daily doses per 1000 inhabitants, while a one percent
increase in doctors between 45 and 54 years old led to a consumption decrease by an average
of 0.10 doses. The results of older age classes (55–64; 65–74) were not significant, but the
results confirm the trend observed in the 45-54-year-old group. Additionally, as the percentage
of GPs increases, there is an average decrease of 0.04 DDD per 1000 inhabitants in hospitaliza-
tion consumption of antibiotics.
Discussion
It is difficult to compare the antibiotic consumption in the community and the hospital sector
among the EU countries due the heterogeneous methodologies used to collect data and due to
poor availability of data over the years under consideration. Nevertheless, it is clear that there
are large variations in community and hospital use of antibiotics in European countries and
Fig 1. Antibiotics use pattern.
https://doi.org/10.1371/journal.pone.0199436.g001
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Table 2. Results of the regression analysis.
Antibiotic consumption Antibiotic consumption
Regressor in the community in the hospital sector
DDD per 1000 DDD per 1000
inhabitants and per day inhabitants and per day
Gini index (%) –0.05 <0.01
(0.10) (0.03)
Time effect 2.27 0.93
(0.006) (0.528)
R2 0.931 0.745
Countries 22 16
Average obs. per country 12.5 11.1
Mean income of households (€ in thousands) –0.21 –0.04
(0.19) (0.05)
Time effect 1.78 0.66
(0.044) (0.805)
R2 0.924 0.672
Countries 20 15
Average obs. per country 12.3 10.9
Educational attainment level (%), 25–64 years, 0.07 –0.02
Upper secondary to Tertiary education (levels 3–8) (0.08) 0.01
Time effect 1.43 0.68
(0.138) (0.791)
R2 0.925 0.673
Countries 22 16
Average obs. per country 14.1 12.5
Unemployment, % of female labor force –0.05 0.01
(0.10) (0.02)
Time effect 2.15 0.91
(0.001) (0.549)
R2 0.924 0.664
Countries 22 16
Average obs. per country 14.3 12.5
Total physicians 35–44 years old (% of total physicians) <0.01 0.08
(0.21) (0.03)
Total physicians 45–54 years old (% of total physicians) 0.13 –0.10
(0.18) (0.05)
Total physicians 55–64 years old (% of total physicians) 0.03 –0.01
(0.17) (0.02)
Total physicians 65–74 years old (% of total physicians) –0.14 –0.05
(0.25) (0.05)
Time effect 2.33 2.15
(0.005) (0.013)
R2 0.934 0.779
Countries 21 15
Average obs. per country 12.8 10.9
Generalist medical practitioners (% of total physicians) –0.07 –0.04
(0.11) (0.01)
Specialist medical practitioners (% of total physicians) 0.01 –0.01
(0.09) (0.01)
Time effect 2.33 1.49
(0.005) (0.125)
R2 0.943 0.796
Countries 22 16
Average obs. per country 10.8 9.4
Notes: Robust standard errors are given in parentheses under the coefficients, and p-values are given in parentheses under the F-statistics of time effect.
The individual coefficient with an asterisk () is significant at the 5% level.
https://doi.org/10.1371/journal.pone.0199436.t002
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that the consumption of antibiotics has remained stable over the years. The Netherlands shows
the lowest total consumption of antibiotics (11.55 DDD) whereas Belgium, France and Italy
had the highest consumption (>30 DDD) in 2014. There was a three-fold difference between
countries with the highest and the lowest use of antibiotics. This difference was already present
in 2000.
This variability among countries may be affected by antimicrobial stewardship programmes
performed in the different European countries. Netherland, which has the lowest levels of anti-
biotic use, was one of the first countries to adopt a universal, national strategy for AMS in all
settings. The Netherland programme started by a Working Party on Antibiotic Policies
founded in 1996, supported by the government since 1999. It aimed to provide educational
tools in the form of national antibiotic use tests, and in the publication of a national blueprint
for an antibiotic policy that can help fellow physicians and pharmacists involved in making
such policies at the local level in hospitals and other stations where antibiotics are dispensed
[15].
Italy, instead, adopted its first National Action Plan on Antimicrobial Resistance (PNCAR)
2017–2020 in November 2017. The PNCAR represents the tool for implementing the Italian
strategy. In order to face the increasing resistance and spread of antibiotic-resistant microor-
ganisms, the PNCAR provides for national coordination, specific objectives and actions
through the synergy between national, regional and local levels, the different key stakeholders
involved and a governance, in which the roles of the institutions are clearly defined [16].
In Belgium, the Belgian Antibiotic Policy Coordination Committee (BAPCOC) was offi-
cially established in 1999 by royal decree. The overall objective of BAPCOC was to promote
judicious use of antibiotics and to promote infection control and hospital hygiene, reducing
antibiotic resistance and optimizing care. To address these specific tasks BAPCOC founded
five multidisciplinary working groups, wich included ambulatory care, hospital care, aware-
ness campaigns, infection control. Specifically, BAPCOC focused on hospital setting through
funding of dedicated staff and technical support to antibiotic stewardship (ABS) teams in all
Belgian hospitals, the training of over 500 healthcare professionals in ABS, integration of sur-
veillance programs on antibiotic use in hospital [17,18].
It is not easy to explain the reason for high level of antibiotic use in France. Over the last
decade, France implemented three national plans to reduce antibiotic prescriptions. As part of
the plans, the French government initiated a long-term nationwide campaign to reduce antibi-
otic overuse and control the dissemination of resistant bacteria in the community. The
national program, named “Keep Antibiotics Working,” was launched in 2001, targeting both
the general public and health care professionals, to encourage surveillance of antibiotic use
and resistance and to promote better-targeted antibiotic use. Since 2002, a public service cam-
paign is launched each winter with the primary goal of decreasing prescriptions. Unfortu-
nately, the impact of these policies has levelled of the antibiotic use, illustrating again the need
for an effective antimicrobial stewardship [19].
Antibiotics consumption in the community continues to account for between 85% and
95% of total consumption in 2014. The highest use in the community was in Belgium, France,
and Italy (28 DDD9) and in the hospital sector in Finland and the UK. The Netherlands had
the lowest use in both of the settings (10.6 DDD and 0.9 DDD, respectively).
These findings of substantial stability may explain the behavior of patients and doctors as
underlined by the extant literature. A recent review [20] concluded that the patient’s demand
and the need to give quick relief to their symptoms seem to favor antibiotics prescriptions as
doctors, especially those in the community, respond to patients’ needs by prescribing antibiot-
ics rather than providing explanations of why antibiotics may not be needed. In addition, pre-
vious studies suggest that some doctors prescribe because they think that patients expect to
Trajectories and predictors of antibiotic consumption
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have antibiotics even when the specific case does not require it [21,22]. To be sure, much of
the literature is unanimous on the idea that practitioners’ judgment of patients’ expectations is
a major influence on prescribing patterns of antibiotics [23].
According to the results, some socioeconomic variables, such as level of education, income,
Gini index and unemployment, are not related to antibiotics consumption in both settings.
However, some other extrapolations may be made. Although the impact is not significant, it
seems that increasing inequality (Gini index) and unemployment rates reduce the consump-
tion of antibiotics in the community. There are no studies that investigate the correlation
between income inequality, unemployment and consumption of antibiotics. A study con-
ducted in Switzerland reported a weak association between income inequality and antimicro-
bial consumption, but no causal link has been established [24]. To justify this correlation,
mediating factors are needed, such as the unequal access to health services. Inequality in
income distribution and poverty can considerably reduce access to health services even if they
are available [25]. Another factor is inequity in the clinical consultation and the prescribing
physician favoring patients who are financially better-off in several of the OECD countries
[26].
The results also show that increasing the average income reduces antibiotic consumption.
Filippini’s study on socioeconomic determinants of regional differences in outpatient antibi-
otic consumption supports this finding, highlighting the notion that income is negatively
related to antibiotics use [7]. In addition, the importance of wealth has been reported again
and again by the WHO [27,28]. In this regard, the WHO believes that the likelihood of doctors
receiving continuing medical education increases with national income, with high-income
countries being more likely to implement policies regarding rational antibiotics use.
Another important finding in this study is that an increase in the proportion of young doc-
tors (<45 years old) may lead to a significant increase in antibiotics prescription and con-
sumption, while an increase in the percentage of older physicians (45–40 years old especially
but still> 50 years old) reduces the consumption of antibiotics.
One possible hypothesis is that practitioners’ experience and professional development
activities influence physicians practice, and these factors are responsible for the differences in
antibiotics prescribing patterns. This suggestion is supported by some literature [29,30],
whereas several qualitative studies have demonstrated that physicians tend to meet patients’
antibiotics demands over time instead of educating them properly about rational drug use
[23,31].
Another important but unexpected result is that as the number of general practitioner
increases, the antibiotics consumption is reduced both in the hospital and community sectors.
It is difficult to find an explanation for this phenomenon. A previous study has shown some
relationship between ambulatory antibiotic use and hospital use. It highlighted the idea that
when the use of antibiotics in one country is high in the community context, it is also likely to
be high in the hospital context and vice versa. Assuming that there is a causal link between the
percentage of general practitioners and antibiotics consumption in the hospital, the mediating
factor that may be most important is the antibiotics consumption pattern in the community.
The reduced use of antibiotic may be attributed to the fact that by increasing the number of
general practitioners in the area, they are able to visit patients, establish a relationship of trust
and prescribe antibiotic therapy more appropriately.
The main weakness of this study is that the analysis of the trend of use was conducted for all
antimicrobials without studying the trajectory of individual antibiotic groups. A focus on indi-
vidual typologies would help to better understand what may justify the stability of the trend
and the typologies with a divergent behavior. A second weakness lies in the fact that the
Trajectories and predictors of antibiotic consumption
PLOS ONE | https://doi.org/10.1371/journal.pone.0199436 June 22, 2018 8 / 11
epidemiology of the population of the European areas has not been analyzed. A study of the
prevalent pathologies would allow a further explanation of this trend in antibiotics use.
Using different indicators of socioeconomic status and different categories of prescribing
physicians and insights from extant literature [32,33], this study’s use of a variety of possible
predictors tends to be its strength. Our analyses contribute to the debate on the pattern of pre-
scription and use of antibiotics. This study provides some understanding about relevant deter-
minant and suggests that DDDs are significantly shaped by the category and the age-group of
prescribing physicians.
Although it is a known fact that antibiotics consumption varies between countries, the cur-
rent study confirms this link through analyzing a 15-year period and 22 EU countries as well
as shows that the consumption of antibiotics has remained stable over the years. These results
may promote and help to define more effective health care policies to reduce the inappropriate
use of antibiotics.
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